Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3674928010 | Niacin 750 mg prolonged-release oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3674929019 | Nicotinic acid 750 mg prolonged-release oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3674930012 | Product containing precisely nicotinic acid 750 milligram/1 each prolonged-release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Nicotinic acid 750 mg prolonged-release oral tablet | Is a | Nicotinic acid only product in oral dose form | true | Inferred relationship | Some | ||
| Nicotinic acid 750 mg prolonged-release oral tablet | Has manufactured dose form | Extended-release oral tablet | true | Inferred relationship | Some | ||
| Nicotinic acid 750 mg prolonged-release oral tablet | Has BoSS | Nicotinic acid | true | Inferred relationship | Some | 1 | |
| Nicotinic acid 750 mg prolonged-release oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Nicotinic acid 750 mg prolonged-release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
| Nicotinic acid 750 mg prolonged-release oral tablet | Has presentation strength numerator value | 750 | false | Inferred relationship | Some | 1 | |
| Nicotinic acid 750 mg prolonged-release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
| Nicotinic acid 750 mg prolonged-release oral tablet | Has precise active ingredient | Nicotinic acid | true | Inferred relationship | Some | 1 | |
| Nicotinic acid 750 mg prolonged-release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Nicotinic acid 750 mg prolonged-release oral tablet | Is a | Nicotinic acid-containing product in oral dose form | false | Inferred relationship | Some | ||
| Nicotinic acid 750 mg prolonged-release oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Description inactivation indicator reference set
FHIR